Author: Fernández-Ruiz, Irene
Title: RAAS inhibitors do not increase the risk of COVID-19 Cord-id: nxrg9fi6 Document date: 2020_5_22
ID: nxrg9fi6
Snippet: According to five new studies, therapy with angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) is not associated with an increased risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or with an increased risk of severe disease or in-hospital death among patients with COVID-19.
Document: According to five new studies, therapy with angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) is not associated with an increased risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or with an increased risk of severe disease or in-hospital death among patients with COVID-19.
Search related documents:
Co phrase search for related documents- ace inhibitor and logistic regression analysis: 1
Co phrase search for related documents, hyperlinks ordered by date